133 related articles for article (PubMed ID: 29845418)
1. End-of-life chemotherapy is associated with poor survival and aggressive care in patients with small cell lung cancer.
Zhu Y; Tang K; Zhao F; Zang Y; Wang X; Li Z; Sun X; Yu J
J Cancer Res Clin Oncol; 2018 Aug; 144(8):1591-1599. PubMed ID: 29845418
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy Near the End of Life for Chinese Patients with Solid Malignancies.
Sheng J; Zhang YX; He XB; Fang WF; Yang YP; Lin GN; Wu X; Li N; Zhang J; Zhai LZ; Zhao YY; Huang Y; Zhou NN; Zhao HY; Zhang L
Oncologist; 2017 Jan; 22(1):53-60. PubMed ID: 27789776
[TBL] [Abstract][Full Text] [Related]
3. Palliative Chemotherapy Near the End of Life in Oncology Patients.
Zhang Z; Chen ML; Gu XL; Liu MH; Zhao WW; Cheng WW
Am J Hosp Palliat Care; 2018 Sep; 35(9):1215-1220. PubMed ID: 29529885
[TBL] [Abstract][Full Text] [Related]
4. Latent class analysis identifies three subtypes of aggressive end-of-life care: a population-based study in Taiwan.
Chen ML; Chen YY; Tang ST
Eur J Cancer; 2013 Oct; 49(15):3284-91. PubMed ID: 23756054
[TBL] [Abstract][Full Text] [Related]
5. Determinants for aggressive end-of-life care for oral cancer patients: a population-based study in an Asian country.
Chang TS; Su YC; Lee CC
Medicine (Baltimore); 2015 Jan; 94(4):e460. PubMed ID: 25634186
[TBL] [Abstract][Full Text] [Related]
6. Impact of Targeted Therapy on the Quality of End-of-Life Care for Patients With Non-Small-Cell Lung Cancer: A Population-Based Study in Taiwan.
Tsai HY; Chung KP; Kuo RN
J Pain Symptom Manage; 2018 Mar; 55(3):798-807.e4. PubMed ID: 29056563
[TBL] [Abstract][Full Text] [Related]
7. Factors Associated With Aggressiveness of End-of-Life Care for Lung Cancer Patients and Associated Costs of Care.
Bylicki O; Rivière F; Tournier C; Canoui-Poitrine F; Grassin F; Margery J; Prodel M; Vainchtock A; Assié JB; Chouaïd C
Clin Lung Cancer; 2021 May; 22(3):e320-e328. PubMed ID: 32646653
[TBL] [Abstract][Full Text] [Related]
8. Escalating Health Care Expenditures in Cancer Decedents' Last Year of Life: A Decade of Evidence from a Retrospective Population-Based Cohort Study in Taiwan.
Hung YN; Liu TW; Wen FH; Chou WC; Tang ST
Oncologist; 2017 Apr; 22(4):460-469. PubMed ID: 28232596
[TBL] [Abstract][Full Text] [Related]
9. Association between survival time with metastatic breast cancer and aggressive end-of-life care.
Accordino MK; Wright JD; Vasan S; Neugut AI; Gross T; Hillyer GC; Hershman DL
Breast Cancer Res Treat; 2017 Nov; 166(2):549-558. PubMed ID: 28752188
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of Platinum-Sensitive Small-Cell Lung Cancer Patients Treated With Platinum/Etoposide Rechallenge: A Multi-Institutional Retrospective Analysis.
Genestreti G; Tiseo M; Kenmotsu H; Kazushige W; Di Battista M; Cavallo G; Carloni F; Bongiovanni A; Burgio MA; Casanova C; Metro G; Scarpi E; Korkmaz T; Selcuk S; Roopa K; Califano R
Clin Lung Cancer; 2015 Nov; 16(6):e223-8. PubMed ID: 25983005
[TBL] [Abstract][Full Text] [Related]
11. Determinants of aggressive end-of-life care for Taiwanese cancer decedents, 2001 to 2006.
Tang ST; Wu SC; Hung YN; Chen JS; Huang EW; Liu TW
J Clin Oncol; 2009 Sep; 27(27):4613-8. PubMed ID: 19704067
[TBL] [Abstract][Full Text] [Related]
12. Palliative Chemotherapy Affects Aggressiveness of End-of-Life Care.
Wu CC; Hsu TW; Chang CM; Lee CH; Huang CY; Lee CC
Oncologist; 2016 Jun; 21(6):771-7. PubMed ID: 27091417
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of Efficacy and Safety of Different Therapeutic Regimens as
Second-line Treatment for Small Cell Lung Cancer].
Li Z; Liu X; Li J; Gao H; Tang C; Li X; Guo W; Qin H; Wang W; Qu L; Chen J
Zhongguo Fei Ai Za Zhi; 2015 May; 18(5):280-8. PubMed ID: 25975298
[TBL] [Abstract][Full Text] [Related]
14. Association of Early Patient-Physician Care Planning Discussions and End-of-Life Care Intensity in Advanced Cancer.
Ahluwalia SC; Tisnado DM; Walling AM; Dy SM; Asch SM; Ettner SL; Kim B; Pantoja P; Schreibeis-Baum HC; Lorenz KA
J Palliat Med; 2015 Oct; 18(10):834-41. PubMed ID: 26186553
[TBL] [Abstract][Full Text] [Related]
15. Preferences for Aggressive End-of-life Care and Their Determinants Among Taiwanese Terminally Ill Cancer Patients.
Liu LN; Chen CH; Liu TW; Lin YC; Lee SC; Tang ST
Cancer Nurs; 2015; 38(3):E9-E18. PubMed ID: 24915466
[TBL] [Abstract][Full Text] [Related]
16. Psychological factors at early stage of treatment as predictors of receiving chemotherapy at the end of life.
Fujisawa D; Temel JS; Traeger L; Greer JA; Lennes IT; Mimura M; Pirl WF
Psychooncology; 2015 Dec; 24(12):1731-7. PubMed ID: 25959002
[TBL] [Abstract][Full Text] [Related]
17. Survival of patients with small cell lung carcinoma in Taiwan.
Kuo YH; Lin ZZ; Yang YY; Shao YY; Shau WY; Kuo RN; Yang JC; Lai MS
Oncology; 2012; 82(1):19-24. PubMed ID: 22269348
[TBL] [Abstract][Full Text] [Related]
18. Low socioeconomic status is associated with more aggressive end-of-life care for working-age terminal cancer patients.
Chang CM; Wu CC; Yin WY; Juang SY; Yu CH; Lee CC
Oncologist; 2014 Dec; 19(12):1241-8. PubMed ID: 25342317
[TBL] [Abstract][Full Text] [Related]
19. Concurrent Hospice Care and Cancer-Directed Treatment for Advanced Lung Cancer and Receipt of Aggressive Care at the End of Life in the Veteran's Health Administration.
Presley CJ; Han L; O'Leary JR; Zhu W; Corneau E; Chao H; Shamas T; Rose M; Lorenz K; Levy CR; Mor V; Gross CP
J Palliat Med; 2020 Aug; 23(8):1038-1044. PubMed ID: 32119800
[No Abstract] [Full Text] [Related]
20. Timing of end-of-life care discussion with performance on end-of-life quality indicators in ovarian cancer.
Lopez-Acevedo M; Havrilesky LJ; Broadwater G; Kamal AH; Abernethy AP; Berchuck A; Alvarez Secord A; Tulsky JA; Valea F; Lee PS
Gynecol Oncol; 2013 Jul; 130(1):156-61. PubMed ID: 23587882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
